CellFE
PrivateLast Round
Series A
Sep 27, 2023
Total Funding Raised
$26.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CellFE operates in Healthcare & Life Sciences and is based in Alameda, California. Its latest recorded funding round was a Series A round in September 2023.
CellFE is a biotechnology company that develops a microfluidic-based intracellular gene delivery platform for transporting gene-editing molecules into human cells to enhance cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellFE Comparables
Compare CellFE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indee Labs | 87% | |
| Portal Biotechnologies | 86% | |
| Avectas | 85% |
For institutional investors. Book with your work email.
CellFE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 27, 2023 | ||||
| Seed | Mar 31, 2020 | ||||
| Grant | Aug 27, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellFE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| Cota Capital | Series A, Seed |
| Dynamk Capital | Series A, Seed |
| Khosla Ventures | Series A |
| Embark Ventures | Seed, Series A |
| M Ventures | Series A |
| Elm Street Ventures | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 115% MoM, reaching 1.9K.
- Apr 30, 2025
Collaborating with Tcelltech GmbH to advance cell therapy development.
For institutional investors. Book with your work email.
CellFE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellFE's valuation, stock price, and market status.
Is CellFE a public or private company?
CellFE is a private company.
What is the current stock price of CellFE?
CellFE is a private company, so its shares have no public market price. Caplight tracks CellFE's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellFE worth (valuation)?
Valuation information for CellFE is not publicly available.
Can I buy CellFE stock?
CellFE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellFE's last funding round?
CellFE's most recent funding round was Series A on September 27, 2023.
Who are the main investors in CellFE?
Key investors in CellFE include Cota Capital, Dynamk Capital, M Ventures.
Will CellFE IPO soon?
No public IPO plans have been announced for CellFE.
How can I track CellFE secondary market activity?
Caplight tracks bids, offers, and trades in CellFE's shares on secondary markets.